-
1
-
-
79958830099
-
Hepatitis C virus resistance to protease inhibitors
-
Halfon, P.; Locarnini, S. Hepatitis C virus resistance to protease inhibitors. J. Hepatol., 2011, 55(1), 192-206.
-
(2011)
J. Hepatol
, vol.55
, Issue.1
, pp. 192-206
-
-
Halfon, P.1
Locarnini, S.2
-
2
-
-
16844366354
-
Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis
-
Genovese, D.; Dettori, S.; Argentini, C.; Villano, U.; Chionne, P.; Angelico, M.; Rapicetta, M. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J. Clin. Microbiol., 2005, 43(4), 1902-1909.
-
(2005)
J. Clin. Microbiol
, vol.43
, Issue.4
, pp. 1902-1909
-
-
Genovese, D.1
Dettori, S.2
Argentini, C.3
Villano, U.4
Chionne, P.5
Angelico, M.6
Rapicetta, M.7
-
3
-
-
70350392817
-
Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate
-
Bahgat, M.M.; Ibrahim, A.A.; Abd-Elshafy, D.N.; Mesalam, A. A.; Gewaid, H.E.; Ismaeil, A.A.; El-Waseef, A.M.; Maghraby, A.S.; Barakat, A.B.; El-Far, M.A.; Ghanem Hel, D.; Mohamed, A.M.; Ali, M.A. Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate. Arch. Virol., 2009, 154(10), 1649-1657.
-
(2009)
Arch. Virol.
, vol.154
, Issue.10
, pp. 1649-1657
-
-
Bahgat, M.M.1
Ibrahim, A.A.2
Abd-Elshafy, D.N.3
Mesalam, A.A.4
Gewaid, H.E.5
Ismaeil, A.A.6
El-Waseef, A.M.7
Maghraby, A.S.8
Barakat, A.B.9
El-Far, M.A.10
Ghanem Hel, D.11
Mohamed, A.M.12
Ali, M.A.13
-
4
-
-
82955236108
-
Anti-HCV drugs in the pipeline
-
Yang, P.L.; Gao, M.; Lin, K.; Liu, Q.; Villareal, V.A. Anti-HCV drugs in the pipeline. Curr. Opin. Virol., 2011, 1(6), 607-616.
-
(2011)
Curr. Opin. Virol
, vol.1
, Issue.6
, pp. 607-616
-
-
Yang, P.L.1
Gao, M.2
Lin, K.3
Liu, Q.4
Villareal, V.A.5
-
5
-
-
79961171672
-
Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors
-
Das, D.; Hong, J.; Chen, S.H.; Wang, G.; Beigelman, L.; Seiwert, S.D.; Buckman, B.O. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorg. Med. Chem., 2011, 19(16), 4690-703.
-
(2011)
Bioorg. Med. Chem
, vol.19
, Issue.16
, pp. 4690-4703
-
-
Das, D.1
Hong, J.2
Chen, S.H.3
Wang, G.4
Beigelman, L.5
Seiwert, S.D.6
Buckman, B.O.7
-
6
-
-
35748953422
-
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus
-
De Francesco, R.; Carfí, A. Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv. Drug Deliv. Rev., 2007, 59(12), 1242-1262.
-
(2007)
Adv. Drug Deliv. Rev.
, vol.59
, Issue.12
, pp. 1242-1262
-
-
De Francesco, R.1
Carfí, A.2
-
7
-
-
0037367315
-
Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
-
De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiv. Res., 2003, 58(1), 1-16.
-
(2003)
Antiv. Res
, vol.58
, Issue.1
, pp. 1-16
-
-
De Francesco, R.1
Tomei, L.2
Altamura, S.3
Summa, V.4
Migliaccio, G.5
-
8
-
-
84977615349
-
New approaches in the treatment of hepatitis C
-
Gonzalez-Grande, R.; Jimenez-Perez, M.; Gonzalez Arjona, C.; Mostazo Torres, J. New approaches in the treatment of hepatitis C. World J. Gastroenterol., 2016, 22(4), 1421-1432.
-
(2016)
World J. Gastroenterol
, vol.22
, Issue.4
, pp. 1421-1432
-
-
Gonzalez-Grande, R.1
Jimenez-Perez, M.2
Gonzalez Arjona, C.3
Mostazo Torres, J.4
-
9
-
-
84904756999
-
Daclatasvir plus sofosbuvir for HCV infection: An oral combination therapy with high antiviral efficacy
-
Asselah, T. Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy. J. Hepatol., 2014, 61(2), 435-8.
-
(2014)
J. Hepatol
, vol.61
, Issue.2
, pp. 435-438
-
-
Asselah, T.1
-
10
-
-
77952268322
-
Development of novel therapies for hepatitis C
-
Lemon, S.M.; McKeating, J.A.; Pietschmann, T.; Frick, D.N.; Glenn, J.S.; Tellinghuisen, T.L.; Symons, J.; Furman, P.A. Development of novel therapies for hepatitis C. Antiv. Res., 2010, 86(1), 79-92.
-
(2010)
Antiv. Res
, vol.86
, Issue.1
, pp. 79-92
-
-
Lemon, S.M.1
McKeating, J.A.2
Pietschmann, T.3
Frick, D.N.4
Glenn, J.S.5
Tellinghuisen, T.L.6
Symons, J.7
Furman, P.A.8
-
11
-
-
84856410313
-
Antiviral strategies in hepatitis C virus infection
-
Sarrazin, C.; Hézode, C.; Zeuzem, S.; Pawlotsky, J.-M. Antiviral strategies in hepatitis C virus infection. J. Hepatol., 2012, 56, S88-S100.
-
(2012)
J. Hepatol
, vol.56
, pp. S88-S100
-
-
Sarrazin, C.1
Hézode, C.2
Zeuzem, S.3
Pawlotsky, J.-M.4
-
12
-
-
33749249403
-
Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors
-
Yan, S.; Appleby, T.; Larson, G.; Wu, J.Z.; Hamatake, R.; Hong, Z.; Yao, N. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. Bioorg. Med. Chem. Lett., 2006, 16(22), 5888-5891.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, Issue.22
, pp. 5888-5891
-
-
Yan, S.1
Appleby, T.2
Larson, G.3
Wu, J.Z.4
Hamatake, R.5
Hong, Z.6
Yao, N.7
-
13
-
-
33845619375
-
Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure
-
Yan, S.; Larson, G.; Wu, J.Z.; Appleby, T.; Ding, Y.; Hamatake, R.; Hong, Z.; Yao, N. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorg. Med. Chem. Lett., 2007, 17(1), 63-67.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, Issue.1
, pp. 63-67
-
-
Yan, S.1
Larson, G.2
Wu, J.Z.3
Appleby, T.4
Ding, Y.5
Hamatake, R.6
Hong, Z.7
Yao, N.8
-
14
-
-
29044433435
-
A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background
-
Graham, D.J.; Stahlhut, M.; Flores, O.; Olsen, D.B.; Hazuda, D. J.; LaFemina, R.L.; Ludmerer, S.W. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background. Antiv. Res., 2006, 69(1), 24-30.
-
(2006)
Antiv. Res.
, vol.69
, Issue.1
, pp. 24-30
-
-
Graham, D.J.1
Stahlhut, M.2
Flores, O.3
Olsen, D.B.4
Hazuda, D.J.5
LaFemina, R.L.6
Ludmerer, S.W.7
-
15
-
-
84960158342
-
IDX-184 is a superior HCV directacting antiviral drug: A QSAR study
-
Elfiky, A.A.; Elshemey, W.M. IDX-184 is a superior HCV directacting antiviral drug: a QSAR study. Med. Chem. Res., 2016, 25, 1005-1008.
-
(2016)
Med. Chem. Res
, vol.25
, pp. 1005-1008
-
-
Elfiky, A.A.1
Elshemey, W.M.2
-
16
-
-
84925270533
-
2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study
-
Elfiky, A.A.; Elshemey, W.M.; Gawad, W. A. 2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study. J. Comput. Theor. Nanosci., 2015, 12(3), 376-386.
-
(2015)
J. Comput. Theor. Nanosci.
, vol.12
, Issue.3
, pp. 376-386
-
-
Elfiky, A.A.1
Elshemey, W.M.2
Gawad, W.A.3
-
17
-
-
84988421322
-
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials
-
Elfiky, A.A. Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials. J. Med. Virol., 2016, 88, 2044-2051.
-
(2016)
J. Med. Virol
, vol.88
, pp. 2044-2051
-
-
Elfiky, A.A.1
-
18
-
-
84892405001
-
The Electronic and quantitative structure activity relationship properties of modified telaprevir compounds as hcv ns3 protease inhibitors
-
Saleh, N.A.; Elfiky, A.A.; Ezat, A.A.; Elshemey, W.M.; Ibrahim, M. The Electronic and quantitative structure activity relationship properties of modified telaprevir compounds as hcv ns3 protease inhibitors. J. Computa. Theore. Nanosci., 2014, 11(2), 544-548.
-
(2014)
J. Computa. Theore. Nanosci
, vol.11
, Issue.2
, pp. 544-548
-
-
Saleh, N.A.1
Elfiky, A.A.2
Ezat, A.A.3
Elshemey, W.M.4
Ibrahim, M.5
-
19
-
-
84925279170
-
Theoretical study on modified boceprevir compounds as ns3 protease inhibitors
-
Saleh, N.A.; Ezat, A.A.; Elfiky, A.A.; Elshemey, W.M.; Ibrahim, M. Theoretical study on modified boceprevir compounds as ns3 protease inhibitors. J. Computat.Theoret. Nanosci., 2015, 12(3), 371-375.
-
(2015)
J. Computat.Theoret. Nanosci
, vol.12
, Issue.3
, pp. 371-375
-
-
Saleh, N.A.1
Ezat, A.A.2
Elfiky, A.A.3
Elshemey, W.M.4
Ibrahim, M.5
-
20
-
-
84896843263
-
MERS: Emergence of a novel human coronavirus
-
Raj, V.S.; Osterhaus, A.D.; Fouchier, R.A.; Haagmans, B.L. MERS: Emergence of a novel human coronavirus. Curr. Opin. Virol., 2014, 5, 58-62.
-
(2014)
Curr. Opin. Virol
, vol.5
, pp. 58-62
-
-
Raj, V.S.1
Osterhaus, A.D.2
Fouchier, R.A.3
Haagmans, B.L.4
-
21
-
-
84872683113
-
Molecular modeling comparison of the performance of NS5b polym erase inhibitor (PSI-7977) on prevalent HCV genotypes
-
Elfiky, A.A.; Elshemey, W.M.; Gawad, W.A.; Desoky, O.S. Molecular modeling comparison of the performance of NS5b polym erase inhibitor (PSI-7977) on prevalent HCV genotypes. Protein J., 2013, 32(1), 75-80.
-
(2013)
Protein J
, vol.32
, Issue.1
, pp. 75-80
-
-
Elfiky, A.A.1
Elshemey, W.M.2
Gawad, W.A.3
Desoky, O.S.4
-
22
-
-
80051670512
-
Protein-protein HADDocking using exclusively pseudocontact shifts
-
Schmitz, C.; Bonvin, A.M. Protein-protein HADDocking using exclusively pseudocontact shifts. J. Biomol NMR, 2011, 50(3), 263-6.
-
(2011)
J. Biomol NMR
, vol.50
, Issue.3
, pp. 263-266
-
-
Schmitz, C.1
Bonvin, A.M.2
-
23
-
-
78650674078
-
Safety and pharmacokinetics of IDX184, a livertargeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects
-
Zhou, X. J.; Pietropaolo, K.; Chen, J.; Khan, S.; Sullivan-Bolyai, J.; Mayers, D. Safety and pharmacokinetics of IDX184, a livertargeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects. Antimicrob. Agents Chemother., 2011, 55(1), 76-81.
-
(2011)
Antimicrob. Agents Chemother
, vol.55
, Issue.1
, pp. 76-81
-
-
Zhou, X.J.1
Pietropaolo, K.2
Chen, J.3
Khan, S.4
Sullivan-Bolyai, J.5
Mayers, D.6
-
24
-
-
23744446809
-
Giacomo Paonessa, Raffaele De Francesco and Giovanni Migliaccio, HCV antiviral resistance: The impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase
-
Licia Tomei, S.A. Giacomo Paonessa, Raffaele De Francesco and Giovanni Migliaccio, HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase. Antiv. Chem. Chemother., 2005, 16, 225-245.
-
(2005)
Antiv. Chem. Chemother
, vol.16
, pp. 225-245
-
-
Licia Tomei, S.A.1
-
25
-
-
84912061839
-
The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors
-
Saleh, N.A. The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors. Spectrochim Acta A Mol. Biomol. Spectrosc., 2014, 136PC, 1523-1529.
-
(2014)
Spectrochim Acta A Mol. Biomol. Spectrosc
, Issue.136PC
, pp. 1523-1529
-
-
Saleh, N.A.1
-
26
-
-
85022150820
-
Hepatitis C Viral Polymerase Inhibition using Directly Acting Antivirals, A Computational Approach
-
A, M., Ed. Austin publishing group: USA, In press
-
Elfiky, A.A.; Gawad, W.A.; Elshemey, W.M. Hepatitis C Viral Polymerase Inhibition using Directly Acting Antivirals, A Computational Approach. In Software and Techniques for Bio-Molecular Modeling, A, M., Ed. Austin publishing group: USA, In press.
-
Software and Techniques for Bio-Molecular Modeling
-
-
Elfiky, A.A.1
Gawad, W.A.2
Elshemey, W.M.3
-
27
-
-
84865392953
-
Structural properties of metal-free apometallothioneins
-
Summers, K.L.; Mahrok, A.K.; Dryden, M.D.; Stillman, M.J. Structural properties of metal-free apometallothioneins. Biochem Biophys. Res. Commun., 2012, 425(2), 485-92.
-
(2012)
Biochem Biophys. Res. Commun
, vol.425
, Issue.2
, pp. 485-492
-
-
Summers, K.L.1
Mahrok, A.K.2
Dryden, M.D.3
Stillman, M.J.4
-
28
-
-
0037470586
-
Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation
-
O’Farrell, D.; Trowbridge, R.; Rowlands, D.; Jäger, J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation. J. Mol. Biol., 2003, 326(4), 1025-1035.
-
(2003)
J. Mol. Biol.
, vol.326
, Issue.4
, pp. 1025-1035
-
-
O’Farrell, D.1
Trowbridge, R.2
Rowlands, D.3
Jäger, J.4
-
29
-
-
77958464322
-
Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis
-
Harrus, D.; Ahmed-El-Sayed, N.; Simister, P.C.; Miller, S.; Triconnet, M.; Hagedorn, C.H.; Mahias, K.; Rey, F.A.; Astier-Gin, T.; Bressanelli, S. Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis. J. Biol. Chem., 2010, 285(43), 32906-18.
-
(2010)
J. Biol. Chem
, vol.285
, Issue.43
, pp. 32906-32918
-
-
Harrus, D.1
Ahmed-El-Sayed, N.2
Simister, P.C.3
Miller, S.4
Triconnet, M.5
Hagedorn, C.H.6
Mahias, K.7
Rey, F.A.8
Astier-Gin, T.9
Bressanelli, S.10
-
30
-
-
67649596234
-
588 in vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication
-
Cretton-Scott, E.; Perigaud, C.; Peyrottes, S.; Licklider, L.; Camire, M.; Larsson, M.; La Colla, M.; Hildebrand, E.; Lallos, L.; Bilello, J. 588 in vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication. J. HepatoL., 2008, 48, S220.
-
(2008)
J. HepatoL.
, vol.48
, pp. S220
-
-
Cretton-Scott, E.1
Perigaud, C.2
Peyrottes, S.3
Licklider, L.4
Camire, M.5
Larsson, M.6
La Colla, M.7
Hildebrand, E.8
Lallos, L.9
Bilello, J.10
-
31
-
-
84899047097
-
Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: A review of its clinical potential
-
Stedman, C. Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential. Therapeut. Advan. Gastroenterol., 2014, 7(3), 131-140.
-
(2014)
Therapeut. Advan. Gastroenterol
, vol.7
, Issue.3
, pp. 131-140
-
-
Stedman, C.1
-
32
-
-
16244415552
-
Mizoribine inhibits hepatitis C virus RNA
-
Naka, K.; Ikeda, M.; Abe, K.-i.; Dansako, H.; Kato, N. Mizoribine inhibits hepatitis C virus RNA. Biophys. Res. Commun., 2005, 330(3), 871-879.
-
(2005)
Biophys. Res. Commun
, vol.330
, Issue.3
, pp. 871-879
-
-
Naka, K.1
Ikeda, M.2
Abe, K.-I.3
Dansako, H.4
Kato, N.5
-
33
-
-
77958464322
-
Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis
-
Harrus, D.; Ahmed-El-Sayed, N.; Simister, P.C.; Miller, S.; Triconnet, M.; Hagedorn, C.H.; Mahias, K.; Rey, F.A.; Astier-Gin, T.; Bressanelli, S. Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis. J. Biol. Chem., 2010, 285(43), 32906-32918.
-
(2010)
J. Biol. Chem
, vol.285
, Issue.43
, pp. 32906-32918
-
-
Harrus, D.1
Ahmed-El-Sayed, N.2
Simister, P.C.3
Miller, S.4
Triconnet, M.5
Hagedorn, C.H.6
Mahias, K.7
Rey, F.A.8
Astier-Gin, T.9
Bressanelli, S.10
|